Avacta Therapeutics said on Monday that it has opened the phase one clinical trial of its second oncology pipeline candidate, ...

David Reese believes that AI’s greatest impact will come from improving the thousands of human-led decisions. If Reese, the ...

Definium Therapeutics (NASDAQ:DFTX) outlined its clinical pipeline and upcoming data catalysts at the Leerink Partners Global ...

Diagnosed with severe spina bifida, baby Nixon receives pioneering stem cell fetal surgery, gaining mobility beyond expectations and hope for the future.

Bicycle Therapeutics is letting more air out of its operations, with plans to deflate its employee count by about 30% and ...

Aplagon has dosed the first patient in its phase 2a HEALING clinical trial evaluating APAC, a first‑in‑class treatment for thrombo‑inflammatory diseases, in people with peripheral arterial occlusive ...

An expert involved in the first successful gene therapy trial for Huntington's Disease discusses the trial results and ...

Stoke Therapeutics is developing a drug designed to reduce seizures and restore some of their lost developmental function.

GLP-1 drugs like Ozempic are reshaping performance, expectations and fairness at work. As access expands, leaders must ...

He wrote a book on anti-white bias. The White House noticed.

Quell Therapeutics has begun its chill phase 1/2 clinical trial evaluating QEL‑005, an autologous CAR‑Treg therapy designed for people with rheumatoid arthritis and systemic sclerosis. The move ...

Quarterly Adjusted EBITDA -- $4.9 million, a $6.3 million improvement from negative $1.4 million in the prior year, with a ...